Atlas Trials

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

Clinical trial NCT01970904 · COMPLETED

Trial details

NCT number
NCT01970904
Sponsor
Debiopharm International SA
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatitis CLiver Disease
Start date
2013-10-01
Primary completion
2015-03-01
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.